Suppr超能文献

小鼠小胶质细胞蛋白酶体的生化分析:干扰素-γ和脂多糖对免疫蛋白酶体的诱导作用

Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.

作者信息

Stohwasser R, Giesebrecht J, Kraft R, Müller E C, Häusler K G, Kettenmann H, Hanisch U K, Kloetzel P M

机构信息

Paul-Ehrlich-Center of Experimental Medicine, Humboldt University Medical School, Institute of Biochemistry, Berlin, Germany.

出版信息

Glia. 2000 Feb 15;29(4):355-65.

Abstract

The 20S proteasome is a multicatalytic threonine protease and serves to process peptides that are subsequently presented as antigenic epitopes by MHC class I molecules. In the brain, microglial cells are the major antigen presenting cells and they respond sensitive to pathologic events. We used cultured mouse microglia and a microglial cell line, the BV-2 line, as a model to study the correlation between microglial activation parameters and structural plasticity of the 20S/26S proteasome. Lipopolysaccharide (LPS)- or interferon-gamma (IFN-gamma)-stimulated microglia or BV-2 cells exhibit properties of activated microglia such as high levels of TNFalpha and IL-6 release. In response to IFN-gamma or LPS, three constitutive beta subunits (beta1/Delta, beta2/MC14, beta5/MB1) were replaced by the immunoproteasome subunits ibeta1/LMP2, ibeta2/MECL-1, and ibeta5/LMP7, indicating that activated microglia adapts its proteasomal subunit composition to the requirements of an optimized MHC class I epitope processing. Induction of immunoproteasomes in BV-2 cells was solely provoked by IFN-gamma, but not by LPS. Moreover, LPS (but not IFN-gamma) triggered the expression of a novel protein of approximately 50 kD as part of the proteasome activator PA700, that is the substrate-recognizing and unfolding unit of the 26S proteasome. These results indicate that both the 20S core protease as well as the proteasome activator PA700 are targets of modulatory subunit replacements or transient association of regulatory components in the course of microglial activation.

摘要

20S蛋白酶体是一种多催化苏氨酸蛋白酶,负责处理随后由MHC I类分子呈递为抗原表位的肽段。在大脑中,小胶质细胞是主要的抗原呈递细胞,它们对病理事件反应敏感。我们使用培养的小鼠小胶质细胞和一种小胶质细胞系BV-2细胞系作为模型,研究小胶质细胞激活参数与20S/26S蛋白酶体结构可塑性之间的相关性。脂多糖(LPS)或干扰素-γ(IFN-γ)刺激的小胶质细胞或BV-2细胞表现出活化小胶质细胞的特性,如高水平的TNFα和IL-6释放。响应IFN-γ或LPS,三个组成型β亚基(β1/Delta、β2/MC14、β5/MB1)被免疫蛋白酶体亚基iβ1/LMP2、iβ2/MECL-1和iβ5/LMP7取代,这表明活化的小胶质细胞使其蛋白酶体亚基组成适应优化的MHC I类表位加工的要求。BV-2细胞中免疫蛋白酶体的诱导仅由IFN-γ引发,而不由LPS引发。此外,LPS(而非IFN-γ)触发了一种约50 kD的新蛋白的表达,该蛋白是蛋白酶体激活剂PA700的一部分,PA700是26S蛋白酶体的底物识别和展开单元。这些结果表明,在小胶质细胞激活过程中,20S核心蛋白酶以及蛋白酶体激活剂PA700都是调节亚基替换或调节成分瞬时结合的靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验